Retirement Systems of Alabama lifted its stake in shares of Monsanto Company (NYSE:MON) by 0.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 256,374 shares of the company’s stock after purchasing an additional 2,085 shares during the quarter. Retirement Systems of Alabama owned 0.06% of Monsanto worth $30,719,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Meyer Handelman Co. raised its stake in shares of Monsanto by 0.6% during the 3rd quarter. Meyer Handelman Co. now owns 124,552 shares of the company’s stock valued at $14,923,000 after purchasing an additional 706 shares during the period. Nikko Asset Management Americas Inc. raised its stake in shares of Monsanto by 1.3% during the 2nd quarter. Nikko Asset Management Americas Inc. now owns 450,700 shares of the company’s stock valued at $53,345,000 after purchasing an additional 5,700 shares during the period. Oakbrook Investments LLC raised its stake in shares of Monsanto by 7.4% during the 3rd quarter. Oakbrook Investments LLC now owns 20,350 shares of the company’s stock valued at $2,438,000 after purchasing an additional 1,400 shares during the period. Aviva PLC increased its stake in Monsanto by 1.2% in the 2nd quarter. Aviva PLC now owns 304,501 shares of the company’s stock worth $36,052,000 after acquiring an additional 3,569 shares during the last quarter. Finally, APG Asset Management N.V. increased its stake in Monsanto by 9.8% in the 3rd quarter. APG Asset Management N.V. now owns 706,078 shares of the company’s stock worth $84,602,000 after acquiring an additional 63,100 shares during the last quarter. Institutional investors own 74.50% of the company’s stock.
MON has been the topic of a number of research analyst reports. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Tuesday, September 12th. Wells Fargo & Company upped their target price on Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research note on Tuesday, October 10th. UBS AG lowered Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price on the stock. in a research note on Friday, August 18th. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Finally, Barclays PLC restated an “equal weight” rating and issued a $124.00 target price (up from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Eleven investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of C$124.61.
In related news, VP Duraiswami Narain sold 2,860 shares of the stock in a transaction dated Monday, September 25th. The stock was sold at an average price of C$120.00, for a total transaction of C$343,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Pierre Courduroux sold 4,320 shares of the stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of C$122.00, for a total value of C$527,040.00. Following the sale, the chief financial officer now owns 48,388 shares of the company’s stock, valued at C$5,903,336. The disclosure for this sale can be found here. Insiders have sold a total of 49,236 shares of company stock valued at $5,931,934 over the last 90 days. 0.79% of the stock is currently owned by company insiders.
Shares of Monsanto Company (NYSE:MON) traded up C$0.96 during mid-day trading on Monday, reaching C$118.30. The company had a trading volume of 2,329,700 shares, compared to its average volume of 1,937,834. The stock has a market cap of $52,075.66, a PE ratio of 21.39, a PEG ratio of 1.70 and a beta of 1.05. Monsanto Company has a 52 week low of C$97.35 and a 52 week high of C$122.79. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.35 and a quick ratio of 0.83.
Monsanto (NYSE:MON) last issued its earnings results on Wednesday, October 4th. The company reported C$0.20 earnings per share for the quarter, beating the consensus estimate of C($0.41) by C$0.61. The company had revenue of C$2.69 billion during the quarter, compared to analysts’ expectations of C$2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. Monsanto’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.07 EPS. research analysts anticipate that Monsanto Company will post 5.74 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This article was reported by Transcript Daily and is owned by of Transcript Daily. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://transcriptdaily.com/2017/11/13/retirement-systems-of-alabama-has-30-72-million-position-in-monsanto-company-mon.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.